(R)-(-)-Glycidyl phthalimide

We are (R)-(-)-Glycidyl phthalimide CAS:181140-34-1 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:(R)-(-)-Glycidyl phthalimide
CAS.NO:181140-34-1
Synonyms:(R)-(-)-Glycidyl phthalimide
(R)-N-Glycidylphthalimide
(R)-N-(2,3-Epoxypropyl)phthalimide
N-(R)-Glycidyl Phthalimide
(R)-4-(Oxiran-2-ylmethyl)isoindoline-1,3-dione
 
Physical and Chemical Properties:
Density 1.4±0.1 g/cm3
Boiling Point 347.4±15.0 °C at 760 mmHg
Melting Point 101ºC
Molecular Formula C11H9NO3
Molecular Weight 203.194
Flash Point 163.9±20.4 °C
 
Specification:
Appearance:White powder
Assay:≥98.0%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Intermediate of Rivaroxaban(CAS:366789-02-8).

(R)-(-)-Glycidyl phthalimide


Related News: Beta Bionics is pursuing regulatory approval of its insulin-only bionic pancreas, followed by its dual-hormone system, which will also administer a glucagon analog in order to raise blood-sugar levels without the need to consume carbohydrates. Beta Bionics operates in Massachusetts and California.147-94-4 At present, Teva can produce more than 300 generic drugs, and the API department has approximately 650 authorized patents and patent applications worldwide. It is also the generic drug company with the most challenges in patenting ParagraphIV in the world.35180-01-9 Targets within the tumor microenvironment may include both plasma membrane proteins as well as proteins typically secreted into the extracellular space.N-Hydroxysuccinimide Targets within the tumor microenvironment may include both plasma membrane proteins as well as proteins typically secreted into the extracellular space.As part of the agreement, ICIG will enter into a 5-year supply contract to provide Genzyme with materials needed for the production of eliglustat tartrate, an investigational treatment for Gaucher disease Type 1 that is currently in Phase III clinical trials.

Related Products
Product Name
2-(morpholin-4-yl)ethanol View Details
2-(2-Aminothiazol-4-yl)acetic acid hydrochloride View Details
(3aR,4S,7R,7aS)-Hexahydro-4,7-methanoisobenzofuran-1,3-dione View Details
5,7-Dihydro-2-methylthieno[3,4-d]pyrimidine manufacturer 3-Chloro-5-(trifluoromethyl)pyridin-2-amine manufacturer 5-[4-[3-chloro-4-[(3-fluorophenyl)methoxy]anilino]quinazolin-6-yl]furan-2-carbaldehyde manufacturer Fmoc-L-alaninol manufacturer 2-Ethoxyphenyl isothiocyanate manufacturer